Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

AM-580

Retinoic acid receptor ligand
 
BML-GR104-0005 5 mg 103.00 USD
 
BML-GR104-0025 25 mg 429.00 USD
Do you need bulk/larger quantities?
 
Retinoic acid analog which acts as a selective RARα agonist with no affinity for RXRs. Induces differentiation in leukemia cell lines and inhibits angiogenesis in chick embryos.

Product Specification

Formula:C22H25NO3
 
MW:351.4
 
CAS:102121-60-8
 
Purity:≥98% (TLC)
 
Appearance:White to off-white solid.
 
Solubility:Soluble in DMSO (25mg/ml) and ethanol (10mg/ml).
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Regulatory Status:RUO - Research Use Only
 
bml-gr104
Please mouse over
bml-gr104

Product Literature References

AM580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells: M. Gianni, et al.; Blood 87, 1520 (1996), Abstract;
Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs: S.C. Brooks, et al.; Blood 87, 227 (1996), Abstract;
Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo: T. Oikawa, et al.; Eur. J. Pharmacol. 249, 113 (1993), Abstract;
Selective synthetic ligands for human nuclear retinoic acid receptors: B. Martin, et al.; Skin Pharmacol. 5, 57 (1992), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Retinoic acid receptor
By biological activity:
Retinoic acid receptor Ligand
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Brochures
Stem Cells
Stem Cells
Download as PDF

All new literature pieces

Recommend this page

 
Keep in touch

©2020 Enzo Life Sciences, Inc.,